Workflow
Saia Announces Retirement of CIO Rohit Lal and Appointment of Successor Tarak Patel
Globenewswire· 2025-10-22 11:30
Core Insights - Saia, Inc. announced the retirement of Rohit Lal, Executive Vice President and Chief Information Officer, after eight years with the company, effective immediately [1][2] - Tarak Patel has been appointed as the new Executive Vice President and Chief Information Officer, bringing extensive experience in technology and digital transformation [1][3] Leadership Transition - Rohit Lal has significantly advanced Saia's digital capabilities and IT infrastructure during his tenure since joining in 2017 [2] - Lal will remain with the company as an advisor until the first quarter of 2026 to ensure a smooth transition [2] New Executive Profile - Tarak Patel previously served as CIO at Smurfit WestRock, leading a global transformation in processes and technologies [3] - Patel has held leadership roles at E. & J. Gallo Winery and Henkel, focusing on enterprise-wide technology initiatives and supply chain integrations [3] - He holds a Bachelor of Science degree in Computer Engineering from the University of California, San Diego [3] Company Overview - Saia, Inc. offers a variety of transportation services, including less-than-truckload, non-asset truckload, expedited, and logistics services [4] - The company operates 213 terminals nationwide, headquartered in Georgia [4]
Lantronix to Report Fiscal 2026 First Quarter Results on Nov. 5, 2025
Globenewswire· 2025-10-22 11:30
IRVINE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (the “Company”) (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions enabling Edge AI Intelligence, today announced it will release financial results from its fiscal 2026 first quarter, ended Sept. 30, 2025, after the close of the market on Wednesday, Nov. 5, 2025. Management will host an investor conference call and audio webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Nov. 5, 2025. To access the live confer ...
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025
Globenewswire· 2025-10-22 11:30
Dapirolizumab pegol (DZP) Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease activity/remission, flares, fatigue, joint pain and quality of lifePresentation of preclinical study of DZP showing minimal to no human placental transfer CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming presentations from studies evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate, i ...
Valour Inc. Launches Sky (SKY) ETP on Spotlight Stock Market, Reaching 100 Listed ETPs
Globenewswire· 2025-10-22 11:30
Core Insights - DeFi Technologies' subsidiary Valour has successfully listed its 100th exchange-traded product (ETP), the Valour Sky (SKY) SEK ETP, on Sweden's Spotlight Stock Market, solidifying its position as the largest issuer of digital asset ETPs globally [1][3][7] Group 1: Company Achievements - Valour has achieved its year-end goal of listing 100 ETPs, which includes a diverse range of products across major European exchanges such as Börse Frankfurt, SIX Swiss Exchange, and London Stock Exchange [4][7] - The listing of SKY marks a significant milestone for Valour, emphasizing its commitment to providing regulated access to digital assets and meeting local demand for transparent crypto exposure [5][6] Group 2: Product Overview - The Valour Sky (SKY) is a governance token for the Sky ecosystem, which is a successor to MakerDAO, allowing holders to participate in protocol governance related to stablecoin and collateralized lending [2][7] - The ETP provides investors with regulated access to a blue-chip DeFi governance asset, enhancing the appeal of digital assets within traditional investment frameworks [7] Group 3: Leadership Commentary - Elaine Buehler, Head of Products at Valour, highlighted that the launch of SKY reflects the evolving landscape of finance, making DeFi accessible to a broader audience [5] - Olivier Roussy Newton, CEO of DeFi Technologies, stated that reaching the 100 ETP target validates the company's product strategy and commitment to delivering regulated access to digital assets at scale [6]
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Globenewswire· 2025-10-22 11:30
Independent DSMB has identified no safety concerns, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitorFourth consecutive positive DSMB recommendation supports the favorable safety profile observed to datePhase 3 study is being conducted under FDA Fast Track Designation, reflecting the significant unmet need in metastatic breast cancer PHILADELPHIA and VANCOUVER, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq ...
FG Nexus Signs Non-Binding Letter of Intent to Sell Quebec Property
Globenewswire· 2025-10-22 11:30
Charlotte, NC, Oct. 22, 2025 (GLOBE NEWSWIRE) -- FG Nexus (Nasdaq: FGNX, FGNXP) (the "Company" or "FG Nexus”), today announced that it has signed a non-binding letter of intent to sell its Quebec property for $10 million. Following repayment of the existing mortgage, the transaction is expected to generate approximately $8 million in net pretax proceeds. "This sale sharpens our focus on becoming the dominant corporate stakeholder of ETH and provides additional cash resources to repurchase shares of FGNX in ...
Digi Power X Appoints Wealth Management Leader Ajay Gupta to its Board of Directors
Globenewswire· 2025-10-22 11:30
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a U.S. developer of Tier III-grade high-performance computing (HPC) infrastructure, today announced the appointment of Ajay Gupta, CPWA, CRPC, CIMA, to its board of directors (the “Board”), effective ...
FinWise Bancorp Announces Strategic Program Agreement with DreamFi, Inc. to Provide Financial Products that Empower Underbanked Communities to Build Financial Stability
Globenewswire· 2025-10-22 11:30
MURRAY, Utah, Oct. 22, 2025 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced a strategic program agreement with DreamFi, Inc. (“DreamFi”), a start-up financial technology company founded by renowned civil rights attorney Ben Crump in partnership with Business Funding Group, a leading provider of SBA loans. DreamFi’s mission is to support the large demographic of underserved and underbanked communities by improving f ...
United Community Banks, Inc. Reports Third Quarter Earnings
Globenewswire· 2025-10-22 11:30
Strong Loan Growth and Margin Expansion Drive Higher Revenue and EPSGREENVILLE, S.C., Oct. 22, 2025 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (United) today announced net income for the third quarter of 2025 of $91.5 million and pre-tax, pre-provision income of $126.0 million. Diluted earnings per share of $0.70 for the quarter represented an increase of $0.32 from the third quarter a year ago and an increase of $0.07 from the second quarter. Note that the third quarter of 2024 included l ...
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
Globenewswire· 2025-10-22 11:30
Appointment reinforces ProMIS Neurosciences’ strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer’s program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that Slanix Paul Alex, Pharm.D., President and Portfolio Manager for Ally Bridge Grou ...